⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
globenewswire.com
CAH
JNJ
PFE
IQV
IOBT
BaseLaunch Announces the Addition of Takeda as New Pharmaceutical Partner to its Biotech Venture Incubator
prnewswire.com
JNJ
ABBV
Cradle AI-powered protein engineering platform serving six of top 25 pharma leaders
prnewswire.com
JNJ
ABBV
GOOG
META
UBER
GNPX
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
businesswire.com
JNJ
Alger Russell Innovation Index Updates for Fourth Quarter 2025
prnewswire.com
CCC
DOX
DUOL
FFIV
GDDY
GNTX
ZBRA
CORT
EA
GILD
JNJ
QRVO
UTHR
VRTX
Adhesive Bandages Market is expected to generate a revenue of USD 4.48 Billion by 2032, Globally, at 3.60% CAGR: Verified Market Research®
globenewswire.com
JNJ
CCRN
SN
BYDDF
Global Gene Therapy Market to Surge to USD 36.55 Billion by 2032 | MarketsandMarkets™
globenewswire.com
BIIB
ALNY
SRPT
JAZZ
PFE
JNJ
BMRN
QURE
AMGN
Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors
prnewswire.com
JNJ
BMY
NextEvo Naturals CBD: How Water-Soluble SmartSorb Technology Addresses the Absorption Problem Most CBD Users Face
accessnewswire.com
JNJ
U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*
prnewswire.com
JNJ